ASELSAN announced the signing of three new international export agreements during its participation in the 58th MEDICA medical exhibition in Germany, as part of its efforts aimed at enhancing the presence of its national medical technologies in global markets.
Details of the New Agreements
The agreements included strategic partnerships aimed at expanding the distribution scope of the company's products specialized in life support and cardiac health:
- Agreement with the French company CITYCARE: aims to supply HEARTLINE AED (Automated External Defibrillator) devices and their accessories.
- Agreement with MEDIAL GLOBAL: aims to export the LIFELINE HLM (heart-lung machine) to 12 different countries.
- Agreement with KOÇ MEDİKAL BIÇAKCILAR: opens the way to export the same device to 5 additional countries.
Why Does This News Matter?
This step comes as part of ASELSAN's strategy to transfer its engineering expertise, spanning more than half a century, to the medical technology sector, contributing to reducing dependence on foreign sources for sensitive medical devices. These technologies, of which more than 13,000 units have been exported to 26 countries so far, are a fundamental pillar in enhancing national industrial capabilities in the health field.
Technical Capabilities of the Exported Devices
The devices included in the agreements feature advanced technical specifications:
- HEARTLINE AED device: relies on an advanced algorithm to analyze electrocardiograms (EKG) to determine the need for electrical shocks, and provides automatic and semi-automatic operation options with audio and visual guidance to support rapid intervention operations in cases of sudden cardiac arrest.
- LIFELINE HLM device: represents the first domestic heart-lung machine in Turkey, and is used in open-heart surgeries to temporarily perform heart and lung functions. It features a precise control system, an easy-to-use user interface, and an advanced sensor infrastructure to ensure monitoring accuracy during surgery.